RecruitingNCT06255197

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

60,000 participants

Start Date

Nov 4, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a multi-center, observational, real-world study for patients with resected lung cancers in China. With the help of a properly designed data processing algorithm and extensively performed data quality assurance, this study aims to harness the potential of real-world big data to (1) describe characteristics and treatment patterns and their evolving trends; (2) discover features associated with overall survival; and (3) address recently-emerging clinical questions.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study (no experimental treatment involved) that collects data on the real-world outcomes of patients who have had surgery to remove lung cancer. The goal is to understand treatment patterns, recovery, and long-term outcomes in the broader population of lung cancer surgery patients. **You may be eligible if...** - You are over 18 years old - You have had surgical resection (removal of part of your lung) for a lung malignancy **You may NOT be eligible if...** - Your medical records are of poor quality, incomplete, or cannot be properly linked to the study database Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06255197


Related Trials